Since Gal-3 appears to be a critical regulator of liver fibrosis attempts have been made to inhibit its activity by means of a specific inhibitor, named GR-MB-02, in mice [337], in rats [338] and in humans [339]. Here, LGALS3 is linked to Hepatic fibrosis.